JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

高用量インフルエンザワクチンの高齢者における入院に対する有効性 (FLUNITY-HD):個別レベルでの総合分析

  • 0Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Lancet +

|

2025年10月20日

|

2025年10月20日

PubMedで要約を見る

まとめ

この要約は機械生成です。

高用量非活性型インフルエンザワクチン (HD-IIV) は,標準用量 (SD-IIV) よりも,高齢者の重篤なアウトカムに対して,より良い保護を提供します. HD-IIVはインフルエンザや肺炎による入院を 大幅に減少させています

科学分野

  • ゲロントロジー
  • ワクチン学
  • 流行病学について

背景

  • デンマークとスペインで実施された2つの大規模試験では,高用量無活性化インフルエンザワクチン (HD-IIV) と標準用量無活性化インフルエンザワクチン (SD-IIV) を比較した.
  • 研究は高齢者の入院の結果に焦点を当てた.
  • 汎用性を高め,ワクチンの相対効果 (rVE) を評価するために,集団分析 (FLUNITY- HD) が実施された.

研究 の 目的

  • 高齢者におけるHD-IIVとSD-IIVを比較した2つのランダム化試験のデータを集約して分析する.
  • 重篤な臨床結果,主にインフルエンザまたは肺炎の入院に対するHD-IIVの相対的なワクチン有効性 (rVE) を評価する.

主な方法

  • 2つの実用的な,個別のランダム化試験 (DANFLU-2とGALFLU) の,事前に指定された,個別レベルのプール分析.
  • 65歳以上の参加者はランダムに (1:1) HD- IIV (60μg HA抗原) またはSD- IIV (15μg HA抗原) を投与された.
  • ワクチン接種後14日から翌年5月31日まで追跡調査を行った.

主要な成果

  • この分析には466,320人の参加者が含まれており,そのうち233,311人がHD-IIV,233,009人がSD-IIVを受けた.
  • HD- IIVは,インフルエンザまたは肺炎の入院に対して8. 8%の相対的なワクチン有効性 (rVE) を示した (p=0. 0082).
  • HD- IIVでは,心肺疾患の入院 (rVE 6. 3%),検査で確認されたインフルエンザの入院 (rVE 31. 9%),全原因の入院 (rVE 2. 2%) が著しく減少した.

結論

  • HD- IIVは,高齢者のインフルエンザや肺炎の入院に対して,SD- IIVよりも優れた保護性を示した.
  • HD- IIVは,心臓呼吸器系および実験室で確認されたインフルエンザ入院を含む二次エンドポイントの発生率を減少させた.
  • HD-IIVの実施は,適格な集団におけるインフルエンザ予防に重大な公衆衛生上の利益をもたらす可能性があります.

関連する概念動画

Drug Dosing: Geriatric Patients 01:15

222

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Vaccinations 01:51

51.2K

Overview

Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...

Pharmacodynamics in Geriatric Patients: Effects of Age 01:27

185

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution 01:00

228

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion 01:18

233

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism 01:18

195

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...